Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Operating Expenses (2018 - 2025)

TELA Bio (TELA) has 8 years of Operating Expenses data on record, last reported at $21.5 million in Q3 2025.

  • For Q3 2025, Operating Expenses fell 3.15% year-over-year to $21.5 million; the TTM value through Sep 2025 reached $87.3 million, down 5.67%, while the annual FY2024 figure was $88.2 million, 4.75% up from the prior year.
  • Operating Expenses reached $21.5 million in Q3 2025 per TELA's latest filing, down from $23.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $23.9 million in Q4 2023 and bottomed at $10.7 million in Q1 2021.
  • Average Operating Expenses over 5 years is $18.7 million, with a median of $19.6 million recorded in 2024.
  • Peak YoY movement for Operating Expenses: soared 70.98% in 2021, then dropped 18.1% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $13.3 million in 2021, then surged by 32.31% to $17.6 million in 2022, then soared by 35.69% to $23.9 million in 2023, then decreased by 18.1% to $19.6 million in 2024, then increased by 9.95% to $21.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $21.5 million in Q3 2025, $23.2 million in Q2 2025, and $23.0 million in Q1 2025.